Biogen Controversy Highlights FDA’s Rules Surrounding Expert Panels
The Food and Drug Administration (FDA)’s approval of Biogen’s Aduhelm was based on shaky data. The resulting controversy continues to [...]
Surface Ophthalmics Announces $25 Million Private Round of Fundraising
Surface Ophthalmics Announces $25 Million Private Round of Fundraising |[21-July-2021]| Proceeds from the capital raise will help to support and [...]
Unforgivable Hypocrisy From FDAs Career CDER Leadership
The FDA leadership team’s hesitancy on Trump’s nCoV-2019 vaccines and hydroxychloroquine somehow didn’t apply to Biogen’s Aduhelm (aducanumab) review. The [...]
US Supreme Court to Consider Medicare Drug Pricing Challenge
The Supreme Court will consider a challenge brought forth by safety net hospitals. A Trump-era ruling leading to reduced drug [...]
Biden’s EO to Boost ‘Competitiveness’ Puts America at Disadvantage
President Biden recently unveiled a new executive order on “Promoting Competition” in the U.S. economy. Though the executive order is [...]
Register Today for IQVIA Institute Webinar on Using RWD in Oncology Clinical Trials
The IQVIA Institute for Human Data Science will host a webinar on Tuesday, August 17th at 10:00 AM EDT. Speakers [...]
Boston biotech’s drug for rare liver disease will cost $385,000 a year
The day after winning its first US drug approval, Boston biotech Albireo Pharma on Wednesday disclosed that its new medicine [...]
Prescription drugs are too expensive for many Americans. These companies are trying to change that
It's an experience millions of Americans have had: you go to the doctor, get a prescription, take it to the [...]
Synthetic data – A new solution solving historic healthcare privacy challenges
We have become all too accustomed – even desensitized – to reading stories of data breaches, misuse and evocative privacy [...]
The Digital Pills Market To Grow With Techno-Savvy Inputs
Persistence Market Research has come up with its latest finding in the form of “The Digital Pills Market” report, wherein [...]
Transforming the National Medicines Policy with a vision for the future
Australia’s National Medicines Policy (NMP) was launched 22 years ago. Since the NMP was first launched, Australia has seen significant [...]
Digital Health Tools Are Finding Business Models – IQVIA’s 2021 Read on the Health of Digital Health
In the Age of COVID, over 90,000 new health apps were released, as the supply of digital therapeutics and wearables [...]
Health Economics & Outcomes Research (HEOR) Services Market: Global Opportunity Analysis and Industry Forecast, 2020-2027
Health Economics & Outcomes Research (HEOR) Services Market: Global Opportunity Analysis and Industry Forecast, 2020-2027 Health Economics & Outcomes Research [...]
Pharma Rewards Democrat in Cash Following His Opposition of Pelosi’s Drug Pricing Bill
Representative Scott Peters was rewarded with large sums of cash donations to his campaign by pharma and lobbyists the day [...]
Social prescribing in community pharmacy: a systematic review and thematic synthesis
Abstract Background: Social prescribing is a tool for healthcare professionals to help connect people in their communities to local, non-clinical [...]
Democrats and Republicans Unite in Pushing for Medicare Negotiation Legislation, Could Save $500 Billion
Bipartisan support is building for legislative mechanisms that would lead to reduced healthcare costs in the United States. One key [...]
Negotiating the changing NHS landscape: five critical shifts the pharma industry must embrace
As the long-awaited Health and Care Bill begins its passage through parliament, Oli Hudson looks at five critical changes resulting [...]
Payers Must Cover HIV Prevention Drugs Without Cost-Sharing in Two Months
Federal regulations will require payers to cover HIV prevention drugs and care. Gilead’s HIV drug Truvada has faced criticism due [...]
Injecting Price Competition into Medicare Part B Drugs
Medicare Part B, which covers outpatient physician services, pays for physician-administered drugs by reimbursing physicians the average cost for each [...]
NHS shares English hospital data with dozens of companies
According to an analysis by the Financial Times, more than 40 companies, from the world’s largest management consultancy and pharmaceutical [...]
Why Are Drug Manufacturers Disregarding Clinical Trial Transparency Regulations?
A recent study found that most pharmaceutical companies do not meet rules demanding transparency in clinical trials. This lack of [...]
Big Data in the Healthcare & Pharmaceutical Industry: 2018 – 2030 – Opportunities, Challenges, Strategies & Forecasts
The report provides answers to the following key questions: – How big is the Big Data opportunity in the healthcare [...]
OKRA.ai collaborates with AWS for Health initiative from Amazon Web Services
OKRA.ai has announced a collaboration with the AWS for Health initiative from Amazon Web Services (AWS) to help upskill pharmaceutical [...]
IQVIA Publishes Report on 2021 Digital Health Trends
The IQVIA Institute has published a report detailing digital trends for 2021. The report highlights the use of wearables and [...]
Sanitized Propaganda: The Fortress of Lies to Censor Truths about Covid-19
By Dr. Gary Null and Richard Gale Global Research, July 22, 2021 We continue to make efforts to remind people [...]